Magnesium Sulfate Reduces Incidence of Atrial Fibrillation after Coronary Arterial Bypass Surgery: What is the Proper Dose? A Randomized Control Trial

Phase 4

Completed

• Conditions: Atrial fibrillation; Magnesium sulfate; atrial fibrillation; CABG; cardiac surgery

• Registration Number: TCTR20140122001
• Lead Sponsor: o

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2012-02-28
• Study Start: 2014-01-22
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

coronary arterial disease that required elective
coronary arterial bypass grafting operation without any exclusion criteria between August 2008
and Febuary 2012

Exclusion Criteria

Sick sinus syndrome
2nd or 3rd degree atrioventricular block
history of AF
any other surgical procedure during the current admissio
Q-wave myocardial infarction in the preceding 6 weeks
Ongoing treatment with amiodarone, digoxin or warfarin
Permanent pacemaker implantation
Valvular regurgitation
Renal failure (serum creatinine > 2.0)
Preoperative serum magnesium level > 4.0 mEq/dl

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
incidence of atrial fibrillation before discharge ECG monitoring

Secondary Outcome Measures

Name	Time	Method
length of stay until discharge days of postoperative admission,length of ICU stay until discharge from ICU days of postoperative ICU stay,Cost of medical care until discharge total cost of hospital stay during same admission